Maureen Howard
Nessuna posizione attualmente
Profilo
Maureen Howard has been Vice President of Research for ChemoCentryx, Inc. since May 2001.
She was Vice President and Director of Research and Development for Corixa Corporation from April 1997 to May 2001 and a Founding Director of the Immunology Department at the DNAX Research Institute from January 1986 to April 1997.
Dr. Howard received a BS degree in Biochemistry from the University of Melbourne and a PhD in Immunology from the Walter and Eliza Hall Institute at the University of Melbourne, Australia.
Precedenti posizioni note di Maureen Howard
| Società | Posizione | Fine |
|---|---|---|
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Direttore Tecnico/Scientifico/R&S | 01/05/2001 |
| DNAX Research, Inc. | Corporate Officer/Principal | 01/04/1997 |
| CHEMOCENTRYX, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Maureen Howard
| University of Melbourne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
| DNAX Research, Inc. |
- Borsa valori
- Insiders
- Maureen Howard
